• Publications
  • Influence
Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance.
TLDR
It was confirmed that laninamivir is unlikely to cause delayed ADRs or a prolonged duration of ADRs despite this drug being a long-acting NAI and the types of ADR observed were similar to those previously observed. Expand
Clinical efficacy of long-acting neuraminidase inhibitor laninamivir octanoate hydrate in postmarketing surveillance
TLDR
Despite laninamivir requiring only the administration of a single dose, it was confirmed to be an effective treatment in more than 90 % of patients with type A or type B influenza virus infections. Expand
Post-Marketing Surveillance of the Safety of Levofloxacin in Japan
TLDR
It was found that patients with nephropathy, patients over 75 years and patients with a history of convulsive diseases were more likely to develop convulsions during LVX therapy, and LVX should be used cautiously in patients with the above risk factors. Expand
[Study on the safety and efficacy of sitafloxacin--results of the use-results survey].
TLDR
This use-results survey confirmed that STFX is a useful antibacterial agent with no serious problems in its safety profile and efficacy rates of over 90% against all infections. Expand
[In vitro activity of sitafloxacin against clinical isolates in 2009].
TLDR
STFX showed the most potent activity against Gram-negative bacteria and anaerobic bacteria of all the antimicrobial agents tested in this study. Expand
Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016/17 Japanese influenza season; comparison with the 2011/12 to 2015/16 seasons.
TLDR
The continuing clinical effectiveness of laninamivir against influenza A (H1N1)pdm09, A ( H3N2), and B, with no safety issues is indicated. Expand
[In vitro activity of sitafloxacin against clinical isolates in 2012].
TLDR
STFX showed the most potent activity against Gram-negative bacteria and anaerobic bacteria of all the antimicrobial agents tested in this study. Expand
In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2016-17 season: Comparison with the 2010-11 to 2015-16 seasons.
TLDR
The results indicate that the sensitivity to the four commonly used NAIs has been maintained and that any change in the effectiveness of these NAIs would be minute. Expand
[Fundamental and clinical studies of cefoperazone in children (author's transl)].
TLDR
The clinical effectiveness of cephalosporin, cefoperazone (CPZ) was judged to be remarkedly effective in 11 children, effective in 5 children and ineffective in 3 children, with an overall effective rate of 84.2%. Expand
[Efficacy and safety of sitafloxacin in patients with urinary tract infections].
TLDR
It is suggested that STFX is a useful antibacterial agent with an efficacy rate of 91.4% against urinary tract infections, with a minimum efficacy rates of 87.2% (against complicated cystitis), and has no serious problems in its safety profile. Expand
...
1
2
3
...